- Home
- LGIH vs CLDX Comparison
LGIH vs CLDX Comparison
Compare LGIH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGIH
- CLDX
- Stock Information
- Founded
- LGIH 2003
- CLDX 1983
- Country
- LGIH United States
- CLDX United States
- Employees
- LGIH N/A
- CLDX N/A
- Industry
- LGIH Homebuilding
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LGIH Consumer Discretionary
- CLDX Health Care
- Exchange
- LGIH Nasdaq
- CLDX Nasdaq
- Market Cap
- LGIH 2.0B
- CLDX 1.7B
- IPO Year
- LGIH 2013
- CLDX 2008
- Fundamental
- Price
- LGIH $77.80
- CLDX $22.46
- Analyst Decision
- LGIH Hold
- CLDX Buy
- Analyst Count
- LGIH 5
- CLDX 8
- Target Price
- LGIH $131.25
- CLDX $61.86
- AVG Volume (30 Days)
- LGIH 201.3K
- CLDX 739.2K
- Earning Date
- LGIH 02-25-2025
- CLDX 03-04-2025
- Dividend Yield
- LGIH N/A
- CLDX N/A
- EPS Growth
- LGIH 9.16
- CLDX N/A
- EPS
- LGIH 8.36
- CLDX N/A
- Revenue
- LGIH $2,253,616,000.00
- CLDX $9,976,000.00
- Revenue This Year
- LGIH N/A
- CLDX N/A
- Revenue Next Year
- LGIH $23.22
- CLDX N/A
- P/E Ratio
- LGIH $9.42
- CLDX N/A
- Revenue Growth
- LGIH 0.68
- CLDX 128.55
- 52 Week Low
- LGIH $77.17
- CLDX $20.91
- 52 Week High
- LGIH $125.83
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- LGIH 32.80
- CLDX 42.55
- Support Level
- LGIH $81.71
- CLDX $22.38
- Resistance Level
- LGIH $88.07
- CLDX $23.69
- Average True Range (ATR)
- LGIH 2.56
- CLDX 1.07
- MACD
- LGIH -0.55
- CLDX 0.03
- Stochastic Oscillator
- LGIH 5.51
- CLDX 44.67
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.